Ankyrin-1 mutations are a major cause of dominant and recessive hereditary spherocytosis. 1996

S W Eber, and J M Gonzalez, and M L Lux, and A L Scarpa, and W T Tse, and M Dornwell, and J Herbers, and W Kugler, and R Ozcan, and A Pekrun, and P G Gallagher, and W Schröter, and B G Forget, and S E Lux
Division of Hematology/Oncology, Children's Hospital, Boston, Massachusetts 02115, USA.

Hereditary spherocytosis (HS) is the most common inherited haemolytic anaemia in Northern Europeans. The primary molecular defects reside in the red blood cell (RBC) membrane, particularly in proteins that link the membrane skeleton to the overlying lipid bilayer and its integral membrane constituents. Ankyrin-1 is the predominant linker molecule. It attaches spectrin, the major skeletal protein, to the cytoplasmic domain of band 3, the RBC anion exchanger. Two-thirds of patients with HS have combined spectrin and ankyrin-1 deficiency; deficiency of band 3 occurs in about 15 to 20% (ref.1). These data suggest that ankyrin-1 or band 3 defects may be common in HS. To test this we screened all 42 coding exons plus the 5' untranslated/promoter region of ankyrin-1 and the 19 coding exons of band 3 in 46 HS families. Twelve ankyrin-1 mutations and five band 3 mutations were identified. Missense mutations and a mutation in the putative ankyrin-1 promoter were common in recessive HS. In contrast, ankyrin-1 and band 3 frameshift and nonsense null mutations prevailed in dominant HS. Increased accumulation of the normal protein product partially compensated for the ankyrin-1 or band 3 defects in some of these null mutations. Our findings indicate that ankyrin-1 mutations are a major cause of dominant and recessive HS (approximately 35 to 65%), that band 3 mutations are less common (approximately 15 to 25%), and that the severity of HS is modified by factors other than the primary gene defect.

UI MeSH Term Description Entries
D008297 Male Males
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D010375 Pedigree The record of descent or ancestry, particularly of a particular condition or trait, indicating individual family members, their relationships, and their status with respect to the trait or condition. Family Tree,Genealogical Tree,Genealogic Tree,Genetic Identity,Identity, Genetic,Family Trees,Genealogic Trees,Genealogical Trees,Genetic Identities,Identities, Genetic,Tree, Family,Tree, Genealogic,Tree, Genealogical,Trees, Family,Trees, Genealogic,Trees, Genealogical
D011110 Polymorphism, Genetic The regular and simultaneous occurrence in a single interbreeding population of two or more discontinuous genotypes. The concept includes differences in genotypes ranging in size from a single nucleotide site (POLYMORPHISM, SINGLE NUCLEOTIDE) to large nucleotide sequences visible at a chromosomal level. Gene Polymorphism,Genetic Polymorphism,Polymorphism (Genetics),Genetic Polymorphisms,Gene Polymorphisms,Polymorphism, Gene,Polymorphisms (Genetics),Polymorphisms, Gene,Polymorphisms, Genetic
D011401 Promoter Regions, Genetic DNA sequences which are recognized (directly or indirectly) and bound by a DNA-dependent RNA polymerase during the initiation of transcription. Highly conserved sequences within the promoter include the Pribnow box in bacteria and the TATA BOX in eukaryotes. rRNA Promoter,Early Promoters, Genetic,Late Promoters, Genetic,Middle Promoters, Genetic,Promoter Regions,Promoter, Genetic,Promotor Regions,Promotor, Genetic,Pseudopromoter, Genetic,Early Promoter, Genetic,Genetic Late Promoter,Genetic Middle Promoters,Genetic Promoter,Genetic Promoter Region,Genetic Promoter Regions,Genetic Promoters,Genetic Promotor,Genetic Promotors,Genetic Pseudopromoter,Genetic Pseudopromoters,Late Promoter, Genetic,Middle Promoter, Genetic,Promoter Region,Promoter Region, Genetic,Promoter, Genetic Early,Promoter, rRNA,Promoters, Genetic,Promoters, Genetic Middle,Promoters, rRNA,Promotor Region,Promotors, Genetic,Pseudopromoters, Genetic,Region, Genetic Promoter,Region, Promoter,Region, Promotor,Regions, Genetic Promoter,Regions, Promoter,Regions, Promotor,rRNA Promoters
D005260 Female Females
D005799 Genes, Dominant Genes that influence the PHENOTYPE both in the homozygous and the heterozygous state. Conditions, Dominant Genetic,Dominant Genetic Conditions,Genetic Conditions, Dominant,Condition, Dominant Genetic,Dominant Gene,Dominant Genes,Dominant Genetic Condition,Gene, Dominant,Genetic Condition, Dominant
D005808 Genes, Recessive Genes that influence the PHENOTYPE only in the homozygous state. Conditions, Recessive Genetic,Genetic Conditions, Recessive,Recessive Genetic Conditions,Condition, Recessive Genetic,Gene, Recessive,Genetic Condition, Recessive,Recessive Gene,Recessive Genes,Recessive Genetic Condition
D006579 Heterozygote An individual having different alleles at one or more loci regarding a specific character. Carriers, Genetic,Genetic Carriers,Carrier, Genetic,Genetic Carrier,Heterozygotes

Related Publications

S W Eber, and J M Gonzalez, and M L Lux, and A L Scarpa, and W T Tse, and M Dornwell, and J Herbers, and W Kugler, and R Ozcan, and A Pekrun, and P G Gallagher, and W Schröter, and B G Forget, and S E Lux
November 2001, The Journal of biological chemistry,
S W Eber, and J M Gonzalez, and M L Lux, and A L Scarpa, and W T Tse, and M Dornwell, and J Herbers, and W Kugler, and R Ozcan, and A Pekrun, and P G Gallagher, and W Schröter, and B G Forget, and S E Lux
January 2019, Acta haematologica,
S W Eber, and J M Gonzalez, and M L Lux, and A L Scarpa, and W T Tse, and M Dornwell, and J Herbers, and W Kugler, and R Ozcan, and A Pekrun, and P G Gallagher, and W Schröter, and B G Forget, and S E Lux
January 2005, Blood cells, molecules & diseases,
S W Eber, and J M Gonzalez, and M L Lux, and A L Scarpa, and W T Tse, and M Dornwell, and J Herbers, and W Kugler, and R Ozcan, and A Pekrun, and P G Gallagher, and W Schröter, and B G Forget, and S E Lux
August 1991, British journal of haematology,
S W Eber, and J M Gonzalez, and M L Lux, and A L Scarpa, and W T Tse, and M Dornwell, and J Herbers, and W Kugler, and R Ozcan, and A Pekrun, and P G Gallagher, and W Schröter, and B G Forget, and S E Lux
January 2001, International journal of hematology,
S W Eber, and J M Gonzalez, and M L Lux, and A L Scarpa, and W T Tse, and M Dornwell, and J Herbers, and W Kugler, and R Ozcan, and A Pekrun, and P G Gallagher, and W Schröter, and B G Forget, and S E Lux
December 1998, Blood cells, molecules & diseases,
S W Eber, and J M Gonzalez, and M L Lux, and A L Scarpa, and W T Tse, and M Dornwell, and J Herbers, and W Kugler, and R Ozcan, and A Pekrun, and P G Gallagher, and W Schröter, and B G Forget, and S E Lux
January 1997, Haematologica,
S W Eber, and J M Gonzalez, and M L Lux, and A L Scarpa, and W T Tse, and M Dornwell, and J Herbers, and W Kugler, and R Ozcan, and A Pekrun, and P G Gallagher, and W Schröter, and B G Forget, and S E Lux
November 1993, Blood,
S W Eber, and J M Gonzalez, and M L Lux, and A L Scarpa, and W T Tse, and M Dornwell, and J Herbers, and W Kugler, and R Ozcan, and A Pekrun, and P G Gallagher, and W Schröter, and B G Forget, and S E Lux
December 2000, Human mutation,
S W Eber, and J M Gonzalez, and M L Lux, and A L Scarpa, and W T Tse, and M Dornwell, and J Herbers, and W Kugler, and R Ozcan, and A Pekrun, and P G Gallagher, and W Schröter, and B G Forget, and S E Lux
January 2018, Acta haematologica,
Copied contents to your clipboard!